GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win

12th November 2021 Uncategorised 0

GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win
aliu
Fri, 11/12/2021 – 11:43

More: GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win
Source: fierce